BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25771465)

  • 1. Seroprevalence of hepatitis viruses and risk factors in blood donors of Veracruz, Mexico.
    Lopez-Balderas N; Bravo E; Camara M; Hernandez-Romano P
    J Infect Dev Ctries; 2015 Mar; 9(3):274-82. PubMed ID: 25771465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence of VHB and VHC serological markers among blood donors in the capital state of Veracruz, Mexico].
    Valerio-Ureña J; Vásquez-Fernández F; Pérez-Sosa JA; Cortazar-Benitez LF; Chávez-Tapia NC; Ruvalcaba-Rojas OA; Torres-Medina V; Ocejo-Rodríguez A
    Gac Med Mex; 2009; 145(3):183-7. PubMed ID: 19685823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon.
    Noubiap JJ; Joko WY; Nansseu JR; Tene UG; Siaka C
    Int J Infect Dis; 2013 Oct; 17(10):e832-7. PubMed ID: 23317526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the serologic and molecular screening of blood donations for the hepatitis B and C viruses in a Mexican Transfusion Center.
    Chiquete E; Sánchez LV; Becerra G; Quintero A; Maldonado M; Panduro A
    Ann Hepatol; 2005; 4(4):275-8. PubMed ID: 16432494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in hepatitis B and hepatitis C seroprevalence among Nepalese blood donors.
    Karki S; Ghimire P; Tiwari BR; Maharjan A; Rajkarnikar M
    Jpn J Infect Dis; 2008 Jul; 61(4):324-6. PubMed ID: 18653982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of hepatitis B and C virus infections among Lao blood donors.
    Jutavijittum P; Yousukh A; Samountry B; Samountry K; Ounavong A; Thammavong T; Keokhamphue J; Toriyama K
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):674-9. PubMed ID: 17883005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies.
    Said ZN; El-Sayed MH; El-Bishbishi IA; El-Fouhil DF; Abdel-Rheem SE; El-Abedin MZ; Salama II
    Liver Int; 2009 Apr; 29(4):518-24. PubMed ID: 19192168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalance of antibodies against hepatitis C and B viruses in patients with systemic lupus erythematosus].
    Mercado U; Avendaño-Reyes M; Araiza-Casillas R; Díaz-Molina R
    Rev Gastroenterol Mex; 2005; 70(4):399-401. PubMed ID: 17058978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing trends in seroprevalence rates of transfusion-transmitted diseases among blood donors in Jordan.
    Souan L; Siag M; Al-Salahat H; Al-Atrash T; Sughayer MA
    BMC Infect Dis; 2021 May; 21(1):508. PubMed ID: 34059011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus and hepatitis C virus seroprevalence in rural areas of the southwestern region of Turkey.
    Akcam FZ; Uskun E; Avsar K; Songur Y
    Int J Infect Dis; 2009 Mar; 13(2):274-84. PubMed ID: 18945630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Seroprevalence of HBV, HCV, and HIV among blood donors in Irapuato, Mexico].
    Carreto-Vélez MA; Carrada-Bravo T; Martínez-Magdaleno A
    Salud Publica Mex; 2003; 45 Supp 5():S690-3. PubMed ID: 14974281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatitis C virus antibodies and genotypes in asymptomatic, first-time blood donors in Namibia.
    Vardas E; Sitas F; Seidel K; Casteling A; Sim J
    Bull World Health Organ; 1999; 77(12):965-72. PubMed ID: 10680243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual positivity of hepatitis B surface antigen and anti-hepatitis C virus antibody and associated factors among apparently healthy patients of Ekiti State, Nigeria.
    Oje OJ; Sule WF; Famurewa D
    Viral Immunol; 2012 Dec; 25(6):448-55. PubMed ID: 23171358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
    Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
    Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of antibodies against hepatitis B virus and hepatitis C virus among blood donors in Lebanon, 1997-2003.
    Irani-Hakime N; Musharrafieh U; Samaha H; Almawi WY
    Am J Infect Control; 2006 May; 34(4):241-3. PubMed ID: 16679184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroepidemiology of hepatitis B and C virus infections among blood donors in Ethiopia.
    Hundie GB; Raj VS; GebreMichael D; Haagmans BL
    J Med Virol; 2017 Jul; 89(7):1300-1303. PubMed ID: 28121005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B and hepatitis C prevalence among blood donors and HIV-1 infected patients in Florianópolis--Brazil.
    Treitinger A; Spada C; Ferreira LA; Neto MS; Reis M; Verdi JC; de Miranda AF; de Oliveira OV; Van der Sander Silveira M; Abdalla DS
    Braz J Infect Dis; 2000 Aug; 4(4):192-6. PubMed ID: 11008223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: a multi-center serosurvey.
    Nascimento MC; Mayaud P; Sabino EC; Torres KL; Franceschi S
    J Med Virol; 2008 Jan; 80(1):53-7. PubMed ID: 18041005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
    Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
    Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of hepatitis C virus and hepatitis B virus among dialysis patients in Bahrain and Saudi Arabia.
    Almawi WY; Qadi AA; Tamim H; Ameen G; Bu-Ali A; Arrayid S; Abou Jaoude MM
    Transplant Proc; 2004; 36(6):1824-6. PubMed ID: 15350487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.